ライフサイエンスコーパス: co-infected

1 ); worldwide more than 15 million people are co-infected.

2 DR tuberculosis who were tested for HIV were co-infected.

3 SARS-CoV-2 infection of whom 29.8% are HIV-1 co-infected.

4 CC-PHHs, either HBV mono-infected or HBV/HDV co-infected.

5 rhosis who were HCV mono-infected or HIV/HCV co-infected.

6 ess towards elimination goals within HIV/HCV co-infected adults in Australia following universal DAA

7 rosis compared with APRI or FIB-4 in HBV/HIV co-infected adults on combined antiretroviral therapy.

8 Twelve HCV/HIV-co-infected and 15 HCV-monoinfected patients underwent v

9 brosis in 8% of all patients (31% in HIV/HCV co-infected and 3% in HIV mono-infected individuals).

10 gorithms and treatment regimens for both HIV co-infected and hepatitis C mono-infected patients are s

11 urvival time in a large cohort of HIV-HTLV-1 co-infected and HIV mono-infected patients on cART.

12 s undetectable at 72 weeks in 25% and 40% of co-infected and monoinfected patients, respectively.

13 The study recruited 120 participants, 36 HIV-co-infected, and 14 cirrhotic.

14 Interestingly, the Th2 response in the co-infected animals did not impair the onset and develop

15 pathway to the heightened susceptibility of co-infected animals.

16 pe 1 to 4 are virtually identical in the HIV co-infected as in the HCV monoinfected, regardless of wh

17 lem hemiparasite, by removing parasites from co-infected branches of a common nitrogen-fixing host, v

18 We matched 149 patients co-infected by HTLV-1 (cases) by age at HIV diagnosis an

19 ce that different Delphinidae species can be co-infected by multiple anelloviruses belonging to disti

20 risingly, at least 5% of the population were co-infected by SARS-CoV-2 of multiple clades within the

21 A HIV patient can be co-infected by two or more genotypes from Northeast BR1

22 hese data demonstrate that hPSC-LOs and hPSC-COs infected by SARS-CoV-2 can serve as disease models t

23 node germinal center B cell response between co-infected C3H and B6 mice.

24 antigen-specific antibody-producing cells in co-infected C3H mice compared to B6 mice as early as 2 w

25 A greater proportion of HBV/HIV co-infected cases were female than HBV mono-infected (6/

26 doplasmic reticulum (ER) and PM fractions of co-infected cells by the anti-FLAG antibody demonstrates

27 P, and more than 75% of rHSV48Y/rAAV-CFP-Neo co-infected cells were positive for both transgene produ

28 replication of wild-type HSV-1 and HSV-2 in co-infected cells.

29 prevent the replication of wild-type HSV in co-infected cells.

30 nd concomitant HIV-1, HIV-2 transcription in co-infected cells.

31 xpression was significantly higher in TB/HIV-co-infected compared with HIV-negative TB or control tis

32 In addition, HBV/HIV co-infected females presented at a younger mean age (36.

33 ys of co-infection, and after 4 weeks 95% of co-infected fleas contained an average of 103 antibiotic

34 n correlation profiles observed in the HIV-1 co-infected group.

35 were hepatitis B-co-infected or hepatitis C-co-infected, had new AIDS-defining conditions within 30

36 peted if has competitive advantages within a co-infected host.

37 This study indicates that co-infected hosts are important source of variation in s

38 Co-infected hosts generated supershedding events of high

39 spore-trapping experiment demonstrates that co-infected hosts shed more transmission propagules than

40 Co-infected hosts, individuals that carry more than one

41 istic Th1/Th2 immune response that occurs in co-infected hosts.

42 and yet malaria populations were smaller in co-infected hosts.

43 Most co-infected individuals can achieve a sustained HCV viro

44 miR-122 and miR-200a are greater in HIV/HCV co-infected individuals compared to HIV-1 mono-infected

45 red with individuals infected with only HIV, co-infected individuals had a higher risk of death from

46 d/or AIDS-related mortality was higher among co-infected individuals than those with only HIV infecti

47 (Enhancing care and treatment among HCV/HIV co-infected individuals to Eliminate Hepatitis C transmi

48 se is recommended for TB diagnosis among HIV co-infected individuals with low CD4 T-cell counts.

49 an achieve similar response rates in HCV/HIV-co-infected individuals with no adverse effect on HIV RN

50 distinguish between disease states in HIV-1 co-infected individuals, and combinations of biomarkers

51 g no primary data, samples of HCV or HIV-HCV co-infected individuals, or samples relying on self-repo

52 lly changed over time and between single and co-infected individuals.

53 an unpredictable exacerbation of disease in co-infected individuals.

54 en and those undergoing treatment for HIV in co-infected individuals.

55 eds to be improved for both monoinfected and co-infected individuals.

56 These were simultaneously co-infected into Sf9 insect cells with recombinant bacul

57 ation, and greater lung pathology in the Mtb-co-infected lung.

58 uberculosis antigens were elevated in TB/HIV-co-infected lymph nodes, and inducible nitric oxide synt

59 Co-infected mice lacking interleukin (IL) 4Ralpha exhibi

60 Colonic epithelial preparations from co-infected mice showed increased expression of c-myc (5

61 creases the bacterial burden in the lungs of co-infected mice.

62 aninogenica-induced inflammation by IL-10 in co-infected mice.

63 thy animals (n = 7) and animals intranasally co-infected (n = 7) with Actinobacillus pleuropneumoniae

64 nofluorescent methods, we determined whether co-infected neurons express MCH or orexin.

65 In co-infected non-human primates, Siglec-1 is highly expre

66 e excluded patients if they were hepatitis B-co-infected or hepatitis C-co-infected, had new AIDS-def

67 Amongst HIV-1 co-infected participants those with low CD4 percentage s

68 HIV/HBV-co-infected participants with detectable HBV DNA prior t

69 ne-hundred-and-fifty-seven patients (58% HIV co-infected) participated.

70 se of morbidity and mortality in the HBV/HIV co-infected patient population.

71 ality adjusted for age was higher in HIV/HCV co-infected patients (subhazard ratio [SHR] = 1.88; 95%

72 XDR tuberculosis has been transmitted to HIV co-infected patients and is associated with high mortali

73 ations predict virologic response in HIV/HCV co-infected patients and to examine variables associated

74 itis C virus (HCV) mono-infected and HIV/HCV co-infected patients are in need of safe, effective, all

75 ths related to HIV in the United States, and co-infected patients bear a significant proportion of th

76 mmunodeficiency virus type 1 (HIV-1) and HBV-co-infected patients because it had been reported that E

77 Compared with HCV-monoinfected patients, co-infected patients had a higher rate of hepatic decomp

78 High mortality rates in co-infected patients have improved with antiretroviral t

79 tion and CYP2B6 enzyme activity among TB-HIV co-infected patients in Ethiopia.

80 drug-resistant tuberculosis (XDR-TB) and HIV co-infected patients in South Africa.

81 Co-infected patients may require longer treatment durati

82 xposure and CYP2B6 enzyme activity in TB-HIV co-infected patients on drug treatment.

83 ofile and SVR12 rates of 96.7% among HIV/HCV co-infected patients participating in an Italian compass

84 rus (HBV)-human immunodeficiency virus (HIV) co-infected patients receiving combined antiretroviral t

85 HCV/human immunodeficiency virus (HIV)-co-infected patients show lower response rates vs. HCV-m

86 study of vitamin D supplementation in HIV-TB co-infected patients starting ART.

87 or without ribavirin (arms B1-3) and HIV/HCV co-infected patients to 12 weeks of therapy with or with

88 SVR12 rates in mono-infected and co-infected patients treated for 12 weeks without ribavi

89 Co-infected patients were randomized within a US multice

90 Co-infected patients who maintained HIV RNA levels less

91 Rates of decompensation were higher for co-infected patients with advanced liver fibrosis, sever

92 3 HCV mono-infected patients and 175 HIV/HCV co-infected patients with cirrhosis, included in two pro

93 usly untreated HCV-mono-infected and HIV/HCV-co-infected patients without cirrhosis achieved SVR12 ra

94 e generally lower in Hepatitis B virus (HBV) co-infected patients, but the mechanism is unknown.

95 the context of human immunodeficiency virus co-infected patients, has threatened global TB control.

96 e, with only 50% case detection among HIV/TB co-infected patients, hence the need to determine the di

97 the standard treatment for HCV infection for co-infected patients, who have the greatest risk for liv

98 hat HBV genotype D was the most prevalent in co-infected patients, with no significant age-related di

99 Ca against HDV in 12 treatment-naive HBV/HDV co-infected patients.

100 V infection has emerged as major concern for co-infected patients.

101 tiation during antituberculosis treatment in co-infected patients.

102 cost of an increased risk of WNV disease in co-infected patients.

103 Predicted clearance time increased by 28% in co-infected patients.

104 cantly elevated in blood samples from TB/HIV-co-infected patients.

105 ment-associated adverse reactions in loiasis co-infected patients.

106 nse in AFB microscopy smear negative PTB-HIV co-infected patients.

107 t ribavirin was similar in mono-infected and co-infected patients.

108 d from 93-98% in mono-infected and 87-97% in co-infected patients.

109 ed with higher rates of decompensation among co-infected patients.

110 HIV/CMV co-infected persons despite prolonged viral suppression

111 We show that HIV/CMV co-infected persons with virologic suppression and recov

112 d more rapid progression of complications in co-infected persons.

113 utility to detect prevalent TB amongst HIV-1 co-infected persons.

114 Here, experimentally co-infected pigs with a representative EA virus and a pd

115 virus by feeding on singly infected plants, co-infected plants, or by sequential feeding on singly i

116 In co-infected primary mouse macrophages, FeoB is required

117 li (EPEC), and ETEC with Campylobacter spp., co-infected significantly more than expected at random (

118 In a subgroup analysis of mono- and co-infected subjects some associations lost significance

119 esting has been previously restricted to HIV co-infected TB patients.

120 of hepatic decompensation was greater among co-infected than monoinfected patients (7.4% vs. 4.8% at

121 S) that were particularly abundant in TB/HIV-co-infected tissues.

122 the antagonism of the viroid on the virus in co-infected tomato plants.

123 n, we find the highest disease prevalence in co-infected treatments both at the host genotype and pop

124 inetic parameters and treatment responses in co-infected vs monoinfected patients.

125 The reduced survival times in mice co-infected with a low dose of T. muris on d 105 after C

126 DNA barcode sequence by allelic exchange and co-infected with a wild-type reference to calculate the

127 Patients co-infected with advanced HIV and tuberculosis are at ri

128 ose consequences are less severe if cats are co-infected with an attenuated FIV strain (PLV).

129 ecies in North America, could potentially be co-infected with avian and human IAVs, facilitating the

130 heterophil to lymphocyte ratios and were all co-infected with avian malaria, consistent with evidence

131 ne of the cases with a virus identified were co-infected with bacterial pathogens.

132 n patients from 2014-2020, four of whom were co-infected with Borrelia spp.

133 a reduction in the number of days pigs were co-infected with both challenge viruses.

134 By contrast, in cultures co-infected with CIP-encoding rAAV2 vectors and rHSV48Y

135 oups at a tertiary hospital with 55 patients co-infected with DRTB and HIV (28 women, 27 men) who wer

136 lected from vaccinated and unvaccinated pigs co-infected with H1N1 and H3N2 IAV strains, and characte

137 Adult patients co-infected with HBV-HIV from eight North American sites

138 that 12.5% of the HCV-infected patients were co-infected with HBV.

139 patients, revealing that 12.5% patients were co-infected with HBV.

140 One quarter of states require persons co-infected with HCV and HIV to be receiving antiretrovi

141 lts of this study generalize to all patients co-infected with HCV and HIV.

142 uncontrolled, pilot study enrolling patients co-infected with HCV genotype 1 and HIV, administration

143 en resulted in high SVR rates among patients co-infected with HCV genotype 1 and HIV-1 whether treate

144 veral cohort studies showed that in patients co-infected with HCV, HBV, or HIV, annual incidence of H

145 V-1-infected patients, two of whom were also co-infected with HCV.

146 Patients co-infected with hepatitis B virus (HBV) and the human i

147 e following transplantation than in patients co-infected with hepatitis C (37 +/- 9 vs. 70 +/- 33 U/L

148 frequently found in transplantation patients co-infected with hepatitis C although it appears to have

149 Persons co-infected with hepatitis C virus (HCV) and HIV.

150 Patients co-infected with hepatitis C virus (HCV) and human immun

151 unodeficiency virus (HIV; PLwH) are commonly co-infected with hepatitis C virus (HCV).

152 s B surface antigen positive (HBsAg) persons co-infected with hepatitis C virus, hepatitis D virus an

153 ldwide, of whom approximately 20 million are co-infected with hepatitis delta virus (HDV).

154 s6-Cdc25C immunoprecipitated from sf-9 cells co-infected with His6-Prk and His6-Cdc25C baculoviruses,

155 When co-infected with His6-Prk and His6-Cdc25C recombinant ba

156 n American, and 13% were Caucasian; 27% were co-infected with HIV and 67% had no or mild fibrosis.

157 eron-free regimens are approved for patients co-infected with HIV and genotype-2 or genotype-3 hepati

158 based regimens are still an option for those co-infected with HIV and HCV genotypes 1 or 4.

159 ent-naive and treatment-experienced patients co-infected with HIV and HCV genotypes 1-4.

160 Despite receiving ART, patients co-infected with HIV and HCV had higher rates of hepatic

161 therapy became widely available, individuals co-infected with HIV and HCV have had a higher risk of d

162 Also, patients co-infected with HIV and HCV in 2001 constituted 7.5 tim

163 emonstrate the optimal management of persons co-infected with HIV and HCV.

164 deline-recommended treatment for individuals co-infected with HIV and hepatitis B, this regimen might

165 ve been incompletely examined among patients co-infected with HIV and hepatitis C virus (HCV) in the

166 %) had no additional restrictions for people co-infected with HIV and hepatitis C virus.

167 during ART should be considered in patients co-infected with HIV and tuberculosis.

168 Older patients and patients co-infected with HIV had a lower CT load suggesting expo

169 onsider women, Hispanic persons, or patients co-infected with HIV or hepatitis B virus.

170 be effective and well tolerated for patients co-infected with HIV with or without cirrhosis.

171 tuberculosis and high mortality among those co-infected with HIV-1 necessitates new therapeutic appr

172 age 35.1 years [IQR 30.1-43.7]) and 76 were co-infected with HIV-1.

173 he effect of ART and HIV-1 viraemia in those co-infected with HIV-1.

174 rom 74 out of 344 patients, 48 of these were co-infected with HIV.

175 us in AFB microscopy smear negative patients co-infected with HIV.

176 cine efficacy against CIN2+, where all cases co-infected with HPV-16/18 were removed, vaccine efficac

177 Patients co-infected with human immunodeficiency virus (HIV) and

178 participants; 69.9% were male and 70.4% were co-infected with human immunodeficiency virus (HIV).

179 epatitis C virus (HCV) infection in patients co-infected with human immunodeficiency virus (HIV).

180 dered allergic to Aspergillus fumigatus were co-infected with influenza A virus and Streptococcus pne

181 Finally, infants co-infected with leading bacteria-bacteria pairs had mor

182 nose BTB is reduced in cattle experimentally co-infected with M. bovis and F. hepatica.

183 eactivation of LTBI, recent work in macaques co-infected with Mycobacterium tuberculosis (Mtb)/simian

184 Experimental data showed that rabbits co-infected with one or both helminths shed significantl

185 lls to tissue macrophages, many of which are co-infected with opportunistic pathogens.

186 nfections presenting with fever was lower if co-infected with P malariae (adjusted odds ratio 0.43, 9

187 al piglets either infected with a single- or co-infected with PDCoV and PEDV using real-time PCR.

188 When humans are co-infected with poliovirus and related non-polio entero

189 higher average temperatures, and individuals co-infected with Pr.

190 When mice were co-infected with prions on d 8 after H. polygyrus infect

191 rcine alveolar macrophages (PAM) cells model co-infected with PRRSV/PCV2 with modification in vitro,

192 me (IRIS) occurs in up to 40% of individuals co-infected with pulmonary tuberculosis (PTB) and HIV, p

193 We show that in cultures co-infected with rAAV-CFP-Neo, 27% of the CFP-positive c

194 stem and immunoprecipitation of insect cells co-infected with RAD51 and RAD52 recombinant viruses, an

195 Cells co-infected with rHSV48Y and rAAV vectors that did not e

196 One matriline was co-infected with Rickettsia and Wolbachia and produced o

197 Rickettsia spp, six RSV, and one participant co-infected with RSV and dengue virus).

198 months, metamorphosed individuals and frogs co-infected with Rv, while Pr intensity was significantl

199 ssion changes in the peripheral blood of PWH co-infected with RV.

200 incapable of causing caries on its own, when co-infected with S. mutans, S. sputigena causes extensiv

201 Animals co-infected with SIVmac251 and M. avium developed progre

202 We enrolled patients (aged >/=18 years) co-infected with stable HIV and chronic HCV genotypes 1-

203 irectly into the CNS and subsequently orally co-infected with T. muris before the onset of clinical s

204 viral titers are often suppressed in insects co-infected with the bacterial endosymbiont Wolbachia.

205 tortaeformis intensity decreased faster when co-infected with the bacterium.

206 iretroviral-induced liver injury in patients co-infected with the human immunodeficiency virus and in

207 d mice were protected when these agents were co-infected with the neuroinvasive strain.

208 While most of the dogs (62.9%) were co-infected with two or more VBPs, having an infection w

209 This restriction is overcome when cells are co-infected with vaccinia virus (VACV), a vertebrate DNA

210 Cells were simultaneously co-infected with viruses encoding alpha-His/beta and alp

211 mposition of the vaginal metabolome in CT/MG co-infected women is unknown.

212 acokinetics study assessed DMPA among HIV/TB co-infected women on an efavirenz-based antiretroviral t

213 (and other body fluids) in 66 HIV- and HHV-8-co-infected women without KS so that we could examine pr